Akebia Therapeutics | AKBA - الربح الإجمالي على المبيعات

سعر السهم
1.35
التغيير اليومي
-0.05 -3.59%
شهريا
11.55%
سنويا
-30.78%
Q1 التوقعات
1.38




الربح الإجمالي على المبيعات تغيير تاريخ
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Amgen USD 6.48B 307M 2025-09
Ardelyx USD 114.37M 8.02M 2025-12
Astellas Pharma JPY 456.81B 38.02B 2025-12
AstraZeneca USD 12.39B 5M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Celltrion KRW 626.11B 81.75B 2025-09
Cspc Pharmaceutical CNY 4.34B 333.68M 2025-09
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Exelixis USD 572.18M 7M 2025-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
J&J USD 16.6B 118M 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
Medical Developments International AUD 7.35M 7.37M 2025-06
Moderna USD 226M 583M 2025-12
Nektar Therapeutics USD 13.75M 650K 2024-06
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pharma Mar EUR 86.7M 53.34M 2025-12
Prothena USD 21K 2.39M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Qiagen NV USD 325.27M 19.53M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Sartorius EUR 393.2M 23M 2025-09
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 57.47M 10.16M 2025-06
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06